Psoriasis Treatment Market Size

Psoriasis Treatment Market size was over USD 30.67 million in 2024 and is anticipated to exceed USD 88.31 million by the end of 2037, witnessing over 8.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of psoriasis treatment is evaluated at USD 32.76 million.

Psoriasis is sometimes considered as a genetic disease that is triggered by surrounding environment. Symptoms often get worse during winter, and infections and psychological stress play a major role in these symptoms. As per the statistics by the World Health Organization (WHO), psoriasis is a serious global problem, with over 100 million individuals affected worldwide at any point of time. Hence, the need for psoriasis treatment has risen owing to the disease's continually expanding patient population. As a result, the market for psoriasis drugs is seeing a significant increase in both demand and supply.

Further, owing to the growing prevalence of psoriasis, the government are increasing its initiatives in order spread awareness regarding psoriasis. Hence, this factor is estimated to boost the demand for psoriasis treatment among people. Also, the market has been greatly boosted by the growing amount of research and development being done in the field of therapeutics by the major market participants. The amount of adverse effects that patients experience after receiving contemporary medicine therapy has decreased as a result of the developments made by the major psoriasis treatment market competitors. Additionally, it has been estimated that the prevalence of psoriasis is higher in the geriatric population. However, it has also been observed that regularity is also growing among young people all around the globe. Therefore, owing to this factor the demand is estimated to rise for the treatment.